A study by Lopes et al. showed that combination therapy of a DNA vaccine encoding the P815A tumor antigen plus antibodies blocking PD-1 and CTLA-4 prolonged survival and reduced tumor growth in murine P815 mastocytoma [168]. Here, CTLA4 is linked to neoplasm.